BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6935533)

  • 1. Urinary system functions in children with intensive antileukemic therapy of acute lymphoblastic leukemia.
    Misíková Z; Lehotská V
    Neoplasma; 1980; 27(4):489-92. PubMed ID: 6935533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunological characteristics of lymphocytes during intensive treatment maintaining remission of acute lymphoblastic leukemia in children and following withdrawal from chemotherapy].
    Kaftański R
    Acta Haematol Pol; 1979; 10(2):99-106. PubMed ID: 289275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective erythroid aplasia during therapy for acute lymphoblastic leukemia.
    Sallan SE; Buchanan GR
    Pediatrics; 1977 Jun; 59(6):895-8. PubMed ID: 266692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intensive treatment results on 426 children with acute lymphoblastic leukemia. Polish Group for the Treatment of Leukemia and Other Neoplastic Diseases of the Hematopoietic System in Children].
    Michalewska D; Radwańska U
    Acta Haematol Pol; 1981; 12(3-4):175-84. PubMed ID: 6952738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The kidney in children under chemotherapy].
    Cachat F; Guignard JP
    Rev Med Suisse Romande; 1996 Dec; 116(12):985-93. PubMed ID: 9026889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen.
    Poplack DG; Reaman GH; Wesley R
    Cancer Treat Rep; 1981; 65 Suppl 4():93-6. PubMed ID: 6955015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testicular function after chemotherapy for acute lymphoblastic leukemia.
    Shalet SM; Lendon M; Morris Jones PH
    N Engl J Med; 1981 Aug; 305(9):520. PubMed ID: 6942224
    [No Abstract]   [Full Text] [Related]  

  • 8. [The function of the immune system after the treatment of pediatric malignant diseases].
    Gadó J; Schlick B; Bárány O; Németh J; Müller J; Csóka M; Constantin T; Vonnák E; Böcskei R; Hauser P; Kovács G
    Orv Hetil; 2006 Sep; 147(36):1731-8. PubMed ID: 17087017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic functions of the liver during chemotherapy in children with acute lymphoblastic leukemia.
    Wiela-Hojenska A; Gorczynska E; Orzechowska-Juzwenko K; Golebiowski W; Hurkacz M; Boguslawska-Jaworska J
    Int J Clin Pharmacol Ther; 2001 Jun; 39(6):246-50. PubMed ID: 11430632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute lymphoblastic leukemia. Problems, antileukemic agents and management.
    Gardner NH
    J Am Med Womens Assoc; 1967 Jan; 22(1):21-7. PubMed ID: 4224850
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth and body composition in response to chemotherapy in children with acute lymphoblastic leukemia.
    Halton JM; Atkinson SA; Barr RD
    Int J Cancer Suppl; 1998; 11():81-4. PubMed ID: 9876486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal current treatment of childhood acute lymphoblastic leukemia.
    Simone JV
    Cancer Treat Rep; 1981; 65 Suppl 4():97-100. PubMed ID: 7049384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood-cerebrospinal fluid barrier in children with acute lymphoblastic leukemia].
    Sroczyńska M; Szczepański Z; Sońta-Jakimczyk D
    Pediatr Pol; 1977 Sep; 52(9):965-9. PubMed ID: 270089
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytogenetic studies of long-term survivors of childhood acute lymphoblastic leukemia.
    Robison LL; Arthur DC; Ball DW; Danzl TJ; Nesbit ME
    Cancer Res; 1982 Oct; 42(10):4289-92. PubMed ID: 6955009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intensive chemotherapy of acute lymphoblastic leukemia in childhood: evaluation of our experience].
    Tontoli N; Correra A; Saviano P; Vetrella A; De Masi RV; Florino G; Lagonigro F
    Pediatria (Napoli); 1981 Dec; 89(4):805-13. PubMed ID: 6955759
    [No Abstract]   [Full Text] [Related]  

  • 17. Dural venous sinus thrombosis in acute lymphoblastic leukemia.
    Lockman LA; Mastri A; Priest JR; Nesbit M
    Pediatrics; 1980 Dec; 66(6):943-7. PubMed ID: 6935625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic abnormalities in adult acute lymphoblastic leukaemia (Burkitt cell type): case report.
    Romeril KR; Concannon AJ; Biggs JC
    N Z Med J; 1981 Oct; 94(694):299-301. PubMed ID: 6948195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level of tau protein in children treated for acute lymphoblastic leukemia.
    Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
    Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cessation of chemotherapy in acute lymphoblastic leukemia. Probable cures and post-suppression relapses].
    Ortega JJ; Javier G
    Sangre (Barc); 1982; 27(5):899-911. PubMed ID: 6963002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.